Indexing
All Issues
Submission
Author Guidelines
Reviewers
Editorial Members
Publication Fee
Vol.3 , No. 4, Publication Date: Jul. 19, 2016, Page: 19-27
–4–amino–5–substitutedamino–1,2,4–triazole(2)and/or3–(pyridin–4yl)–4–amino–5–hydrazino–1,2,4–triazole(7) with α,β–bifunctional compounds such as chloromethyl diphenyl phosphonic acid phenacyl bromide, pyruvic acid, diethyloxalate, triethyl phosphite, triethyl orthoformte, fluorinated benzaldehydes, ethylchloroformate and carbon disulfide in different conditions. Moreover, compounds 3, 6, 8, 7, 9, 10, 11 and 12 displayed high inhibition against all bacteria tested in compared with the standard antibiotic Indomethacin. The newly synthesized compounds were evaluated for their in vivo anti–inflammatory activities and the results revealed that the compounds 7,8,10 and 12 have high % inhibition of edema as compared to standard drug (Indomethacin). Molecular docking studies were performed in order to investigate the plausible binding modes of synthesized compounds 8 and 10 into the active sites of enzyme COX–II.&picture=http://www.aascit.org/aascit/decorators/img/journal/905.jpg)
| [1] | Labeeb M. Shaif, Department of Chemistry, Faculty of Science, Ibb University, Ibb, Yemen. |
| [2] | Faisel M. Aqlan, Department of Chemistry, Faculty of Science, King Abdul–Aziz Univeristy, Jeddah Kingdom of Saudi Arabia. |
| [3] | Khalid O. AL–Footy, Department of Chemistry, Faculty of Science, King Abdul–Aziz Univeristy, Jeddah Kingdom of Saudi Arabia. |
| [4] | Waddhaah M. A. Alasbahy, Department of Chemistry, Faculty of Science, Ibb University, Ibb, Yemen. |
Anovel series of 1,2,4–triazolo[4,3–b][1,2,4]triazines3–6and1,2,4–triazolo[1,2,4,5] tetrazines 8–12 weresynthesizedbyusingheterocyclizationof3–(pyridin–4yl)–4–amino–5–substitutedamino–1,2,4–triazole(2)and/or3–(pyridin–4yl)–4–amino–5–hydrazino–1,2,4–triazole(7) with α,β–bifunctional compounds such as chloromethyl diphenyl phosphonic acid phenacyl bromide, pyruvic acid, diethyloxalate, triethyl phosphite, triethyl orthoformte, fluorinated benzaldehydes, ethylchloroformate and carbon disulfide in different conditions. Moreover, compounds 3, 6, 8, 7, 9, 10, 11 and 12 displayed high inhibition against all bacteria tested in compared with the standard antibiotic Indomethacin. The newly synthesized compounds were evaluated for their in vivo anti–inflammatory activities and the results revealed that the compounds 7,8,10 and 12 have high % inhibition of edema as compared to standard drug (Indomethacin). Molecular docking studies were performed in order to investigate the plausible binding modes of synthesized compounds 8 and 10 into the active sites of enzyme COX–II.
Keywords
Tetrazines, Anti–inflammatory, Antibacterial, Molecular Docking
Reference
| [01] | Mavrova A. T., Wesselinova D., Tsenov Y. A., Denkova P., Eru. J. Med. Chem.44 (2009) 69. |
| [02] | Poulomi M., Anita P., Manabendra P.B., Ajaya K. B., Chem. Rev., 114 (2014) 2942. |
| [03] | Riveiro, M. E., Kimpe, N. D., Moglioni, A.; Vazquez, R. Monczor, F., Shayo, C., Davio, C., Curr. Med. Chem.17 (2010) 1325. |
| [04] | Kulkarni, M. V., Kulkarni, G. M., Lin, C. H., Sun C. M., Curr. Med. Chem. 13 (2006) 2795. |
| [05] | Katiyar, D., Singh, L. K., Curr. Med. Chem. 18 (2011) 2174. |
| [06] | Sobhi M. G., Fathy M. A., Aly H. A., Peter M., Heterocycles. 92 (2016) 945. |
| [07] | Mamolo M. G., Falagiani V., Zampieri D., Vio L., Banfi, E., Farmaco, 55 (2000) 590. |
| [08] | Schleiss M., Eickhoff J., Auerochs S., Leis M., Abele S., Rechter S., Choi Y., Antiviral Res. 79 (2008) 49. |
| [09] | Russell M. G., Carling R. W., Street L. J., Hallett D. J., Goodacre S., Mezzogori E., Reader M., Cook S. M., Bromidge F. A., Newman R., Smith A. J., Wafford K. A., Marshall G. R., Reynolds D. S., Dias R., Ferris P., Stanley J., Lincoln R., Tye S. J., Sheppard W. F., Sohal B., Pike A., Dominguez M., Atack J. R., Castro J. L., J. Med. Chem. 49 (2006) 1235. |
| [10] | Gregory L. B., Donna M. N., Branko S. J., Bioorganic & Medicinal Chemistry. 22 (2014) 4629. |
| [11] | Dolzhenko A. V., Tan B. J., Chiu G. N., Chiu W. K., J. Fluorine Chem.129 (2008) 242. |
| [12] | Ali T. E. S., Eur. J. Med. Chem. 44 (2009) 4539. |
| [13] | Abdel–Monem W. R., Abdel–Rahman R. M., Inter. J. Chem. 16 (2006)1. |
| [14] | El–Gendy Z., Morsy J., Allimony H, Abdel–Monem W. R., Abdel–Rahman R. M., Sulfur and Silicon. 178 (2003) 2055. |
| [15] | Anas M. H. S, Ashok K. S, Nulgumnalli M. R, Rajashri R. N., Med. Chemistry. 12 (2016) 90. |
| [16] | Radwan E., Reem I. A., Molecules. 20 (2015) 5374. |
| [17] | El–Gendy Z., J Morsy, Allimony H., Abdel–Monem W. R., Abdel–Rahman R. M., Inter. J. Chem. 178 (2003) 2055. |
| [18] | Abdel–Rahman R. M., Abdel–Monem W. R., Indian J. Chem. 46B (2007) 838. |
| [19] | Barry A. L., Thomsbery C., Susceptibility testing diffusion testes procedure in Manual of clinical Microbiology, American Society for Microbiology, Washington, (1981) 561. |
| [20] | El–Haggar R., Al–Wabli R. I., Molecules. 20 (2015) 5374. |
| [21] | Santosh S. C., Chandra shekhar D. U., Arabian J. Chem. (2012) In Press. |
| [22] | Kelsey, C., Duggan, K., Walters, Musee, J., Harp, J., Kiefer, J., Oates, J., Marnett, L. J., Biol. Chem. 285 (2010) 34950. |
| [23] | El–Sayed M. A–A., Abdel–Aziz N. I., Abdel–Aziz A. A–M., El–Azab A. S., Asiri Y. A., El–Tahir K. E. H, Bioorg. Med. Chem. 19 (2011) 3416. |
